Neurogenetics tests in Dubai & UAE

Compare available Neurogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

-1.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurogenetics test prices

Showing 16–30 of 68 matching tests.

Neurogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3778 CHMP2B Gene Amyotrophic Lateral Sclerosis Type 17 (ALS17) Genetic Test This genetic test identifies pathogenic variants in the CHMP2B gene associated with Amyotrophic Lateral Sclerosis Type 17 (ALS17). It confirms the molecular basis of the condition.	Peripheral Whole Blood (3–5 mL in EDTA tube) or FTA Card DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CHMP2B gene", "Presence of mutations causing ALS17"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected diagnosis of ALS17", "Family history of ALS17", "Differential diagnosis of motor neuron disease"] Measurement technique Confirm with laboratory Codes LOINC: 94845-8 ICD-10: G12.21 Clinical summary This genetic test identifies pathogenic variants in the CHMP2B gene associated with Amyotrophic Lateral Sclerosis Type 17 (ALS17). It confirms the molecular basis of the condition.
TEST-5406 COASY Gene Neurodegeneration with Brain Iron Accumulation Type 6 Genetic Test This genetic test identifies pathogenic variants in the COASY gene associated with Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6).	Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COASY gene", "Coverage of coding exons and flanking intronic regions (±10 bp)"] Parameters [] Preparation ["No fasting required.", "Continue prescribed medications unless advised otherwise by a neurologist."] Indications ["Suspected diagnosis of Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6)", "Patients with progressive dystonia and characteristic MRI findings"] Measurement technique Confirm with laboratory Codes LOINC: 21635-8 ICD-10: G23.0 Clinical summary This genetic test identifies pathogenic variants in the COASY gene associated with Neurodegeneration with Brain Iron Accumulation Type 6 (NBIA6).
TEST-4702 CSF1R Gene Leukoencephalopathy (Diffuse Hereditary with Spheroids) Genetic Test This test evaluates the CSF1R gene for mutations associated with Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS/ALSP). It identifies pathogenic variants to confirm a d...	Peripheral whole blood (EDTA)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CSF1R gene", "Copy number variations (CNVs) in the CSF1R gene"] Parameters [] Preparation ["No specific fasting required", "No special medication or diet restrictions"] Indications ["Patients with clinical features suggestive of HDLS/ALSP", "Individuals with white matter abnormalities on MRI consistent with HDLS/ALSP", "Family members of individuals diagnosed with HDLS/ALSP for familial variant testing", "Undiagnosed adult leukodystrophies"] Measurement technique Confirm with laboratory Codes LOINC: 94712-8 ICD-10: G37.8 Clinical summary This test evaluates the CSF1R gene for mutations associated with Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS/ALSP). It identifies pathogenic variants to confirm a diagnosis in patients with suggestive clinical and imaging findings.
TEST-5785 CYP2U1 Gene SPG56 Next‑Generation Sequencing (NGS) Genetic Test This test evaluates the CYP2U1 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 56 (SPG56).	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP2U1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Pre-test genetic counselling is recommended", "No specific fasting required"] Indications ["Suspected diagnosis of hereditary spastic paraplegia type 56 (SPG56)", "Confirmation of clinical diagnosis", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 101342-4 ICD-10: G11.4 Clinical summary This test evaluates the CYP2U1 gene for pathogenic variants associated with autosomal recessive hereditary spastic paraplegia type 56 (SPG56).
TEST-5462 DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B (HMN7B) Genetic Test This test identifies pathogenic variants in the DCTN1 gene associated with Distal Hereditary Motor Neuropathy Type 7B (HMN7B).	Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DCTN1 gene", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations (CNV)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected diagnosis of Distal Hereditary Motor Neuropathy Type 7B (HMN7B)", "Family history of HMN7B", "Genetic counselling for individuals with motor neuron disease symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 94059-9 ICD-10: G12.29, G60.0, Z84.81 Clinical summary This test identifies pathogenic variants in the DCTN1 gene associated with Distal Hereditary Motor Neuropathy Type 7B (HMN7B).
TEST-3853 DNAJC3 Gene-Related Combined Cerebellar and Peripheral Ataxia with Hearing Loss and Diabetes Mellitus Test This test detects pathogenic variants in the DNAJC3 gene, confirming a rare autosomal recessive syndrome characterized by cerebellar ataxia, peripheral neuropathy, sensorineural he...	Whole Blood (peripheral) / Extracted DNA / Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNAJC3 gene pathogenic variants", "Cerebellar ataxia", "Peripheral neuropathy", "Sensorineural hearing loss", "Early-onset diabetes mellitus"] Parameters [{"name": "DNAJC3 Coverage", "reference_range": "100% coding region & splice sites"}, {"name": "Diagnostic Sensitivity", "reference_range": ">99.9% for DNAJC3"}] Preparation ["No specific fasting required.", "Inform phlebotomist of any medications."] Indications ["Suspected DNAJC3-related combined cerebellar and peripheral ataxia with hearing loss and diabetes mellitus", "Family history of the condition"] Measurement technique Confirm with laboratory Codes LOINC: 81303-8 ICD-10: G11.9, E11.9, H90.5 Clinical summary This test detects pathogenic variants in the DNAJC3 gene, confirming a rare autosomal recessive syndrome characterized by cerebellar ataxia, peripheral neuropathy, sensorineural hearing loss, and early-onset diabetes mellitus.
TEST-3842 DRD4 Gene ADHD Genetic Test This test evaluates the entire coding region of the DRD4 gene for variants associated with ADHD susceptibility.	Whole blood, extracted DNA, or finger-prick FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DRD4 gene variants", "Dopamine D4 receptor polymorphisms"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Assessment of genetic risk for ADHD", "Support for clinical diagnosis of ADHD"] Measurement technique Confirm with laboratory Codes LOINC: 21665-8 ICD-10: F90.0, F90.1, F90.2, F90.8, F90.9 Clinical summary This test evaluates the entire coding region of the DRD4 gene for variants associated with ADHD susceptibility.
TEST-1028 DRPLA (Dentatorubral-Pallidoluysian Atrophy) Gene Analysis Test This test detects the number of CAG repeats in the ATN1 gene to diagnose DRPLA.	Peripheral whole blood	5 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAG trinucleotide repeat expansion in the ATN1 gene"] Parameters [{"name": "CAG Repeat Number", "reference_range": "Normal: 45 repeats"}] Preparation ["No fasting required", "No special preparation needed"] Indications ["Individuals with symptoms suggestive of DRPLA", "Family history of DRPLA or unexplained neurodegenerative disease", "Differential diagnosis of hereditary ataxias"] Measurement technique Confirm with laboratory Codes LOINC: 90982-3 ICD-10: G11.8 Clinical summary This test detects the number of CAG repeats in the ATN1 gene to diagnose DRPLA.
TEST-5880 EEF2 Gene Spinocerebellar Ataxia Type 26 (SCA26) Autosomal Dominant Genetic Test This test identifies pathogenic variants in the EEF2 gene associated with Spinocerebellar Ataxia Type 26 (SCA26). It provides a definitive molecular diagnosis for this specific typ...	Whole blood (EDTA), extracted genomic DNA, or FTA card blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EEF2 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all medications"] Indications ["Clinical suspicion of Spinocerebellar Ataxia Type 26 (SCA26)", "Family history of SCA26", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-9 ICD-10: G11.8 Clinical summary This test identifies pathogenic variants in the EEF2 gene associated with Spinocerebellar Ataxia Type 26 (SCA26). It provides a definitive molecular diagnosis for this specific type of adult-onset ataxia.
TEST-4693 EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test This test sequences the EIF2B1 gene to identify mutations associated with Vanishing White Matter Disease (VWM), a rare leukodystrophy.	Peripheral whole blood (EDTA tube)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the EIF2B1 gene", "Coding regions and splice sites of the EIF2B1 gene"] Parameters [] Preparation [] Indications ["Suspected Vanishing White Matter Disease (VWM)", "Childhood ataxia with central nervous system hypomyelination", "Leukodystrophy investigation", "Carrier detection", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94047-7 ICD-10: G93.8 Clinical summary This test sequences the EIF2B1 gene to identify mutations associated with Vanishing White Matter Disease (VWM), a rare leukodystrophy.
TEST-4697 EIF2B3 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test This test identifies pathogenic variants in the EIF2B3 gene associated with leukoencephalopathy with vanishing white matter (VWM). It uses Next-Generation Sequencing (NGS) to analy...	Peripheral Whole Blood or Saliva (Oragene DNA Collection Kit)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants", "Small insertions or deletions in EIF2B3 gene"] Parameters [] Preparation [] Indications ["Clinical diagnosis of VWM", "Carrier detection", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 59078-9 ICD-10: G37.8 Clinical summary This test identifies pathogenic variants in the EIF2B3 gene associated with leukoencephalopathy with vanishing white matter (VWM). It uses Next-Generation Sequencing (NGS) to analyze the entire coding region and conserved splice junctions.
TEST-3880 EN2 Gene Autism Spectrum Disorder Genetic Test This test evaluates the EN2 gene for pathogenic variants linked to autism spectrum disorder risk.	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Buccal Swab	21 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EN2 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Clinical suspicion of Autism Spectrum Disorder", "Family history of neurodevelopmental disorders", "Personalised early intervention strategies", "Informed family planning"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: F84.0 Clinical summary This test evaluates the EN2 gene for pathogenic variants linked to autism spectrum disorder risk.
TEST-5351 EOMES Gene Neuronal Migration Disorder Genetic Test This genetic test evaluates the EOMES gene for pathogenic variants associated with neuronal migration disorders.	Whole Blood, Extracted DNA, or FTA Card Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EOMES gene", "Mutations linked to neuronal migration disorders"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected neuronal migration disorder", "Diagnosis of microcephaly or polymicrogyria", "Family history of related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q04.8 Clinical summary This genetic test evaluates the EOMES gene for pathogenic variants associated with neuronal migration disorders.
TEST-4496 FXN Gene Friedreich Ataxia Genetic Test This test evaluates the FXN gene for mutations associated with Friedreich ataxia.	Peripheral Whole Blood (Venous Draw or Finger-Prick FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GAA trinucleotide repeat expansions", "Point mutations in the FXN gene"] Parameters [] Preparation ["Pre-test counseling is mandatory", "Informed consent required"] Indications ["Suspected Friedreich ataxia based on clinical presentation", "Family history of Friedreich ataxia", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 21779-6 ICD-10: G11.1 Clinical summary This test evaluates the FXN gene for mutations associated with Friedreich ataxia.
TEST-5457 GARS1 Gene Distal Hereditary Motor Neuropathy Type 5 (dHMN5) Genetic Test This test evaluates the GARS1 gene for pathogenic variants associated with Distal Hereditary Motor Neuropathy Type 5 (dHMN5). It identifies single nucleotide variants, small insert...	Whole Blood (1–4 mL in EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GARS1 gene coding exons", "GARS1 gene splice sites"] Parameters [] Preparation ["No fasting required", "Continue prescribed medications unless advised otherwise by neurologist", "Inform phlebotomist of bleeding disorders or anticoagulant use"] Indications ["Suspected Distal Hereditary Motor Neuropathy Type 5 (dHMN5)", "Family history of dHMN5", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 99269-5 ICD-10: G60.0 Clinical summary This test evaluates the GARS1 gene for pathogenic variants associated with Distal Hereditary Motor Neuropathy Type 5 (dHMN5). It identifies single nucleotide variants, small insertions/deletions, and copy number variations.

Category overview

Neurogenetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurogenetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurogenetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.